Forum Logikmemorial
Comment fonctionne notre forum => Accueil => Discussion démarrée par: MethrenRaf le Décembre 08, 2024, 03:40:29 pm
-
Fwge Tom Barrett officially becomes U.S. Ambassador to Luxembourg
An experimental drug could be a vital player in the plight to end the opioid epidemic.It s known as VX-548, and its creator,Vertex Pharmaceuticals, said Tuesday the drug s use in late-stage clinical trials resulted in clinically meaningful reduction in pain, without many of the risks associated with opioids.In two trials, patients who had recently undergone surgery and received Vertex s painkiller had statistically significant pain relief over a 48-hour period compared to the placebo group.A smaller study focusing on a wider range of pain conditions used the treatment for up to 14 days and also landed a positive result, with more than 83% of pain patients sa stanley cups (https://www.stanleycups.it) ying VX-548 was good to excellent at treating pain.Vertex noted VX-548 was safe and well-tolerated in all three studies, but it failed to work better than hydrocodone bitartrate/acetaminophen 鈥?the combination that makes up the opioid Vicodin 鈥?in post-surgery patients.Still, the results of Vertex s tri stanley taza (https://www.stanley1913.com.es) als pave a path toward gaining the U.S. Food and Drug Administration s stanley cup (https://www.stanley-mugs.us) approval, thereby providing the U.S. another pain treatment option outside of the dangerous world of opioids.And Vertex plans to do so, saying it will submit a New Drug Application to the FDA by mid-2024 regarding VX-548 s treatment of moderate-to-severe acute pain.SEE MORE: Seattle morgue struggles to store bodies amid fentanyl overdose surgeAcute pain is typically brought on by something specific like surgery, broken bones, dental work or childbirth Saqb MCSO addresses viral video of deputy striking teen during arrest at Milwaukee County Zoo
The CDC-backed website, VaccineFinder.org, has now been updated to include COVID-19 vaccine locations nationwide, sharing information about where supplies have been shipped to hopefully help eligible people find appointments. The idea is to show where COVID-19 vaccine providers [are] that are open to the public 鈥?how to contact them, how to book an appointment, and try to show the daily inventory status so people are clear where there s vaccine and where there isn t, John Brownstein, the founder of VaccineFinder and Chief Information Officer at Boston Children s Hospital told NPR.Those looking to get a vaccine will still need to contact the pharmacy or clinic listed on the VaccineFinder.org website either by phone or online to check they still have vaccine supply and to actually make the appointment.VaccineFinder.org shows which locations have been given vaccine supply directly from the federal government, and may not include all locations that have received their supply from the state or county health departme stanley mug (https://www.stanley-cup.ca) nts.Right now, the website includes more inform stanley termosar (https://www.stanleycup.com.se) ation from locations in Alaska, Indiana, Iowa and Tennessee, including hospitals, clinics, and public vaccination centers.They are working to add more locations and providers in the coming weeks, the website says.The website, VaccineFinder.org, started nine years ago after the H1N1 pandemic and lists locations for flu vaccines and stanley hrnek (https://www.stanley-cup.cz) other common vaccinations. The CDC worked with doctors and engineers at Boston Childrens Ho